Literature DB >> 16006771

Tumour-stromal interactions in breast cancer: the role of stroma in tumourigenesis.

Jong B Kim1, Robert Stein, Mike J O'Hare.   

Abstract

Mammary stromal tissue has a major role in the control and regulation of physiological processes in the breast. Recently, the function of stroma in supporting the tumourigenic process as well as responding to the oncogenic lesion has become clearer. This review differs from the conventional view in that it focuses on and discusses the newly available evidence that points to the fact that mammary stroma has a significant contribution in actively generating transformed lesions and tumours. As such, the oncogenic signals can be dependent or independent of genetic mutations in mammary stromal cells. As a supportive and responsive agent in tumourigenesis, the stroma is induced by tumour cells to express critical signals that drive proliferation, angiogenesis, and motility while suppressing cell death. As an oncogenic agent in tumourigenesis, the stroma can provoke tumourigenicity in adjacent cells in the absence of pre-existing tumour cells leading to the acquisition of genomic changes. Investigating the mechanism by which the tumourigenic cues of the stroma facilitate the generation of malignant epithelial cells will provide invaluable insights into the oncogenic process. Copyright (c) 2005 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2005        PMID: 16006771     DOI: 10.1159/000086950

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  33 in total

1.  Comparative study of stromal metalloproteases expression in patients with benign hyperplasia and prostate cancer.

Authors:  Safwan Escaff; Jesús M Fernández; Luis O González; Aurelio Suárez; Salomé González-Reyes; José M González; Francisco J Vizoso
Journal:  J Cancer Res Clin Oncol       Date:  2010-05-28       Impact factor: 4.553

2.  Stromal caveolin-1 expression in breast carcinoma. Correlation with early tumor recurrence and clinical outcome.

Authors:  Saba Mohamed El-Gendi; Mohamed Farouk Mostafa; Ahmed Mohamed El-Gendi
Journal:  Pathol Oncol Res       Date:  2011-11-07       Impact factor: 3.201

Review 3.  Overexpression of caveolin-1 in cancer-associated fibroblasts predicts good outcome in breast cancer.

Authors:  Wang Shan-Wei; Xu Kan-Lun; Ruan Shu-Qin; Zhao Li-Li; Chen Li-Rong
Journal:  Breast Care (Basel)       Date:  2012-12       Impact factor: 2.860

4.  Breast cancer-associated fibroblasts confer AKT1-mediated epigenetic silencing of Cystatin M in epithelial cells.

Authors:  Huey-Jen L Lin; Tao Zuo; Ching-Hung Lin; Chieh Ti Kuo; Sandya Liyanarachchi; Shuying Sun; Rulong Shen; Daniel E Deatherage; Dustin Potter; Lisa Asamoto; Shili Lin; Pearlly S Yan; Ann-Lii Cheng; Michael C Ostrowski; Tim H-M Huang
Journal:  Cancer Res       Date:  2008-12-15       Impact factor: 12.701

5.  Dissecting the transcriptional networks underlying breast cancer: NR4A1 reduces the migration of normal and breast cancer cell lines.

Authors:  Annika N Alexopoulou; Maria Leao; Otavia L Caballero; Leonard Da Silva; Lynne Reid; Sunil R Lakhani; Andrew J Simpson; John F Marshall; A Munro Neville; Parmjit S Jat
Journal:  Breast Cancer Res       Date:  2010-07-19       Impact factor: 6.466

6.  High expression of thymidine phosphorylase in basal-like breast cancers: Stromal expression in EGFR- and/or CK5/6-positive breast cancers.

Authors:  Shinobu Umemura; Masatoshi Shirane; Susumu Takekoshi; Yutaka Tokuda; Kazushige Mori; Robert Y Osamura
Journal:  Oncol Lett       Date:  2010-03-01       Impact factor: 2.967

7.  The fibromatosis signature defines a robust stromal response in breast carcinoma.

Authors:  Andrew H Beck; Inigo Espinosa; C Blake Gilks; Matt van de Rijn; Robert B West
Journal:  Lab Invest       Date:  2008-04-14       Impact factor: 5.662

Review 8.  Deciphering the molecular basis of breast cancer metastasis with mouse models.

Authors:  Ann E Vernon; Suzanne J Bakewell; Lewis A Chodosh
Journal:  Rev Endocr Metab Disord       Date:  2007-09       Impact factor: 6.514

Review 9.  Microengineered tumor models: insights & opportunities from a physical sciences-oncology perspective.

Authors:  Peter DelNero; Young Hye Song; Claudia Fischbach
Journal:  Biomed Microdevices       Date:  2013-08       Impact factor: 2.838

10.  COX-2 (PTGS2) gene methylation in epithelial, subepithelial lymphocyte and stromal tissue compartments in a spectrum of esophageal squamous neoplasia.

Authors:  Sonja P Dawsey; Mark J Roth; Lisa Adams; Nan Hu; Quan-Hong Wang; Philip R Taylor; Karen Woodson
Journal:  Cancer Detect Prev       Date:  2008-07-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.